STAT3 represses nitric oxide synthesis in human macrophages upon Mycobacterium tuberculosis infection

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Queval, Christophe J ^a   Song, Ok Ryul ^a   Deboosère, Nathalie ^a   Delorme, Vincent ^a   Debrie, Anne Sophie ^a   Iantomasi, Raffaella ^a   Veyron Churlet, Romain ^a   Jouny, Samuel ^a   Redhage, Keely ^a   Deloison, Gaspard ^a   Baulard, Alain ^a   Chamaillard, Mathias ^a   Locht, Camille ^a   Brodin, Priscille ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ANIMAL; CELL LINE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANIMALS; CELL LINE; CHEMOKINE CCL4; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RAW 264.7 CELLS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84978401128     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29297     Document Type: Article

References (58)

1. WHO. Global Tuberculosis Report 2015. (World Health Organization, 2015).
2. BoseDasgupta, S. and Pieters, J. Striking the Right Balance Determines TB or Not TB. Frontiers in immunology 5, 455, doi: 10.3389/fimmu.2014.00455 (2014).
3. Cambier, C. J., Falkow, S. and Ramakrishnan, L. Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis. Cell 159, 1497-1509, doi: 10.1016/j.cell.2014.11.024 (2014).
4. Torrado, E. and Cooper, A. M. Cytokines in the balance of protection and pathology during mycobacterial infections. Advances in experimental medicine and biology 783, 121-140, doi: 10.1007/978-1-4614-6111-1-7 (2013).
5. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. and Altare, F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10, 943-948, doi: 10.1038/ni.1781 (2009).
6. Davis, J. M. and Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49, doi: 10.1016/j.cell.2008.11.014 (2009).
7. Ulrichs, T. and Kaufmann, S. H. New insights into the function of granulomas in human tuberculosis. The Journal of pathology 208, 261-269, doi: 10.1002/path.1906 (2006).
8. Subbian, S. et al. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits. Cell communication and signaling: CCS 11, 60, doi: 10.1186/1478-811X-11-60 (2013).
9. Koo, M.-S., Subbian, S. and Kaplan, G. Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. Cell Communication and Signaling 10, 2 (2012).
10. Darnell, J. E. Jr., Kerr, I. M. and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
11. Ihle, J. N. The Stat family in cytokine signaling. Current opinion in cell biology 13, 211-217 (2001).
12. Levy, D. E. and Darnell, J. E. Jr. Stats: transcriptional control and biological impact. Nature reviews. Molecular cell biology 3, 651-662, doi: 10.1038/nrm909 (2002).
13. Copeland, N. G. et al. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29, 225-228 (1995).
14. Santos, C. I. and Costa-Pereira, A. P. Signal transducers and activators of transcription-from cytokine signalling to cancer biology. Biochimica et biophysica acta 1816, 38-49, doi: 10.1016/j.bbcan.2011.03.003 (2011).
15. Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977 (2010).
16. Chapgier, A. et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS genetics 2, e131, doi: 10.1371/journal.pgen.0020131 (2006).
17. Dupuis, S. et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300-303, doi: 10.1126/science.1061154 (2001).
18. Sabri, A. et al. Association study of genes controlling IL-12-dependent IFN-gamma immunity: STAT4 alleles increase risk of pulmonary tuberculosis in Morocco. The Journal of infectious diseases, doi: 10.1093/infdis/jiu140 (2014).
19. Rottenberg, M. E. and Carow, B. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis. Semin Immunol 26, 518-532, doi: 10.1016/j.smim.2014.10.004 (2014).
20. Akira, S. IL-6-regulated transcription factors. The international journal of biochemistry and cell biology 29, 1401-1418 (1997).
21. Akira, S. et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71 (1994).
22. Boulton, T. G. et al. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proceedings of the National Academy of Sciences of the United States of America 92, 6915-6919 (1995).
23. Niemand, C. et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. The Journal of Immunology 170, 3263-3272 (2003).
24. Stahl, N. et al. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353 (1995).
25. Resemann, H. K., Watson, C. J. and Lloyd-Lewis, B. The Stat3 paradox: a killer and an oncogene. Molecular and cellular endocrinology 382, 603-611, doi: 10.1016/j.mce.2013.06.029 (2014).
26. Troegeler, A. et al. An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages. Immunol Cell Biol, doi: 10.1038/icb.2014.39 (2014).
27. Schworer, S. A. et al. Toll-like Receptor-Mediated Downregulation of the Deubiquitinase CYLD Protects Macrophages from Necroptosis in Wild-Derived Mice. The Journal of biological chemistry, doi: 10.1074/jbc.M114.547547 (2014).
28. Wu, W. K., Llewellyn, O. P., Bates, D. O., Nicholson, L. B. and Dick, A. D. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 215, 796-803, doi: 10.1016/j.imbio.2010.05.025 (2010).
29. Xiong, M., Elson, G., Legarda, D. and Leibovich, S. J. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. The American journal of pathology 153, 587-598, doi: 10.1016/S0002-9440(10)65601-5 (1998).
30. Miller, E. W. and Chang, C. J. Fluorescent probes for nitric oxide and hydrogen peroxide in cell signaling. Current opinion in chemical biology 11, 620-625, doi: 10.1016/j.cbpa.2007.09.018 (2007).
31. Christophe, T. et al. High content screening identifies decaprenyl-phosphoribose 2′ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog 5, e1000645, doi: 10.1371/journal.ppat.1000645 (2009).
32. Queval, C. J. et al. A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. Journal of visualized experiments: JoVE, e51114, doi: 10.3791/51114 (2014).
33. Lastrucci, C. et al. Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16 monocyte population via the IL-10/STAT3 axis. Cell Res, doi: 10.1038/cr.2015.123 (2015).
34. El Kasmi, K. C. et al. General nature of the STAT3-activated anti-inflammatory response. J Immunol 177, 7880-7888 (2006).
35. Yasukawa, H. et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4, 551-556, doi: 10.1038/ni938 (2003).
36. Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C. and Schaper, F. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. The Journal of biological chemistry 275, 12848-12856 (2000).
37. Murray, P. J. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proceedings of the National Academy of Sciences of the United States of America 102, 8686-8691, doi: 10.1073/pnas.0500419102 (2005).
38. Bogdan, C. and Schleicher, U. Production of interferon-gamma by myeloid cells-fact or fancy? Trends Immunol 27, 282-290, doi: S1471-4906(06)00120-7 (2006).
39. Darwich, L. et al. Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 126, 386-393, doi: 10.1111/j.1365-2567.2008.02905.x (2009).
40. Iyer, S. S., Ghaffari, A. A. and Cheng, G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J Immunol 185, 6599-6607 (2010).
41. Akira, S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17, 138-146, doi: 10.1002/stem.170138 (1999).
42. Redford, P. S., Murray, P. J. and OGarra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal immunology 4, 261-270, doi: 10.1038/mi.2011.7 (2011).
43. Behar, S. M., Divangahi, M. and Remold, H. G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nature reviews. Microbiology 8, 668-674 (2010).
44. Parandhaman, D. K. and Narayanan, S. Cell death paradigms in the pathogenesis of infection. Frontiers in cellular and infection microbiology 4, 31, doi: 10.3389/fcimb.2014.00031 (2014).
45. Behar, S. M. et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal immunology 4, 279-287 (2011).
46. Yuk, J. M. et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6, 231-243 (2009).
47. Chan, J., Xing, Y., Magliozzo, R. S. and Bloom, B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175, 1111-1122 (1992).
48. Chan, J., Tanaka, K., Carroll, D., Flynn, J. and Bloom, B. R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 63, 736-740 (1995).
49. Adams, L. B., Dinauer, M. C., Morgenstern, D. E. and Krahenbuhl, J. L. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tubercle and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 78, 237-246 (1997).
50. MacMicking, J. D. et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 94, 5243-5248 (1997).
51. Yang, C. S., Yuk, J. M. and Jo, E. K. The role of nitric oxide in mycobacterial infections. Immune Netw 9, 46-52, doi: 10.4110/in.2009.9.2.46 (2009).
52. Aston, C., Rom, W. N., Talbot, A. T. and Reibman, J. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. American journal of respiratory and critical care medicine 157, 1943-1950, doi: 10.1164/ajrccm.157.6.9705028 (1998).
53. Jung, J. Y. et al. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun 81, 3198-3209, doi: 10.1128/IAI.00611-13 (2013).
54. Lee, J. S. et al. Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-gamma in Human Macrophages after Mycobacterial Infection. Immune Netw 9, 192-202, doi: 10.4110/in.2009.9.5.192 (2009).
55. Rockett, K. A. et al. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 66, 5314-5321 (1998).
56. Sakala, I. G. et al. Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1beta and nitric oxide. Infect Immun 81, 1974-1983, doi: 10.1128/IAI.01393-12 (2013).
57. Rich, E. A. et al. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tubercle and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 78, 247-255 (1997).
58. Abadie, V. et al. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106, 1843-1850, doi: 10.1182/blood-2005-03-1281 (2005).